| __timestamp | HUTCHMED (China) Limited | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 116287000 |
| Thursday, January 1, 2015 | 67426000 | 136004000 |
| Friday, January 1, 2016 | 59752000 | 203017000 |
| Sunday, January 1, 2017 | 65383000 | 287023000 |
| Monday, January 1, 2018 | 70165000 | 393541000 |
| Tuesday, January 1, 2019 | 44738000 | 376095000 |
| Wednesday, January 1, 2020 | 39457000 | 467938000 |
| Friday, January 1, 2021 | 97894000 | 504714000 |
| Saturday, January 1, 2022 | 115306000 | 580017000 |
| Sunday, January 1, 2023 | 453552000 | 523742000 |
Igniting the spark of knowledge
In the dynamic world of pharmaceuticals, understanding financial health is crucial. Over the past decade, HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc. have showcased intriguing gross profit trajectories. From 2014 to 2023, Supernus Pharmaceuticals consistently outperformed, with a peak gross profit in 2022, marking a 400% increase from 2014. Meanwhile, HUTCHMED saw a remarkable surge in 2023, achieving a gross profit nearly 23 times higher than in 2014. This growth reflects strategic advancements and market positioning. While Supernus maintained steady growth, HUTCHMED's recent leap suggests a potential shift in the competitive landscape. Investors and analysts should watch these trends closely, as they offer insights into the evolving pharmaceutical sector and the financial strategies driving success.
Who Generates Higher Gross Profit? AstraZeneca PLC or Supernus Pharmaceuticals, Inc.
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs HUTCHMED (China) Limited
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Incyte Corporation vs HUTCHMED (China) Limited
Viatris Inc. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.